OncoSec Medical, Inc. (ONCSQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
OncoSec Medical Cash from Operations (TTM)
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| January 31, 2023 | -24.99M |
| October 31, 2022 | -28.40M |
| July 31, 2022 | -32.14M |
| April 30, 2022 | -33.63M |
| January 31, 2022 | -41.09M |
| October 31, 2021 | -41.92M |
| July 31, 2021 | -41.79M |
| April 30, 2021 | -42.75M |
| January 31, 2021 | -38.16M |
| October 31, 2020 | -34.75M |
| July 31, 2020 | -33.15M |
| April 30, 2020 | -31.88M |
| January 31, 2020 | -31.35M |
| October 31, 2019 | -30.36M |
| July 31, 2019 | -29.00M |
| April 30, 2019 | -27.13M |
| January 31, 2019 | -25.24M |
| October 31, 2018 | -24.92M |
| July 31, 2018 | -23.22M |
| April 30, 2018 | -21.63M |
| January 31, 2018 | -20.32M |
| October 31, 2017 | -18.00M |
| July 31, 2017 | -17.34M |
| April 30, 2017 | -16.78M |
| January 31, 2017 | -17.04M |
| Date | Value |
|---|---|
| October 31, 2016 | -17.58M |
| July 31, 2016 | -17.81M |
| April 30, 2016 | -18.97M |
| January 31, 2016 | -19.30M |
| October 31, 2015 | -18.88M |
| July 31, 2015 | -17.65M |
| April 30, 2015 | -15.14M |
| January 31, 2015 | -12.52M |
| October 31, 2014 | -10.36M |
| July 31, 2014 | -8.980M |
| April 30, 2014 | -7.569M |
| January 31, 2014 | -6.770M |
| October 31, 2013 | -6.371M |
| July 31, 2013 | -5.533M |
| April 30, 2013 | -5.630M |
| January 31, 2013 | -4.931M |
| October 31, 2012 | -4.505M |
| July 31, 2012 | -4.219M |
| April 30, 2012 | -3.864M |
| January 31, 2012 | -3.174M |
| October 31, 2011 | -2.236M |
| July 31, 2011 | -1.309M |
| April 30, 2011 | -0.2717M |
| January 31, 2011 | -0.021M |
| October 31, 2010 | -0.0115M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 160.32M |
| Alnylam Pharmaceuticals, Inc. | 885.89M |
| Savara, Inc. | -110.38M |
| Vericel Corp. | 69.67M |
| Biogen, Inc. | 2.879B |